Related Experiment Video
Updated: Apr 28, 2026
10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
9.4K
Sofosbuvir (Sovaldi) for the treatment of hepatitis C
Brian Lam1, Linda Henry, Zobair Younossi
1Betty and Guy Beatty Liver and Obesity Research Program, Claude Moore Education and Research Building, Fairfax Hospital, Falls Church, VA 22042, USA.
Expert Review of Clinical Pharmacology
|June 12, 2014
Summary
Sofosbuvir (SOF) is a new direct-acting antiviral for Hepatitis C virus (HCV) infection. Clinical trials show SOF-containing regimens are safe, effective, and well-tolerated across all HCV genotypes, improving patient outcomes.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) infection is a significant global health concern causing chronic liver disease.
- Previous treatments like pegylated-interferon and ribavirin had limited efficacy and significant side effects.
- First-generation direct-acting antivirals (DAAs) improved efficacy but introduced new side effects.
Purpose of the Study:
- To review the clinical experience and efficacy of Sofosbuvir (SOF)-containing regimens for Hepatitis C virus (HCV) treatment.
- To evaluate the safety and tolerability profile of SOF in diverse patient populations.
- To highlight the impact of SOF on patient-reported outcomes in HCV management.
Main Methods:
- Review of clinical trial data on Sofosbuvir (SOF) efficacy and safety.
- Analysis of SOF's mechanism of action as an HCV-specific uridine nucleotide analog inhibitor of NS5B polymerase.
- Assessment of patient-reported outcomes from studies involving SOF-based therapies.
Main Results:
- Sofosbuvir (SOF) is an approved HCV treatment in the USA, Canada, and Europe.
- SOF-containing regimens demonstrate high efficacy and safety across all HCV genotypes.
- These regimens are well-tolerated, leading to improved patient-reported outcomes.
Conclusions:
- Sofosbuvir (SOF) represents a significant advancement in Hepatitis C virus (HCV) treatment.
- SOF-based therapies offer a safe and effective option for patients with all HCV genotypes.
- The improved safety and efficacy profile of SOF enhances patient well-being and treatment adherence.
More Related Videos
06:28Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
13.1K
09:11Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
20.3K
Related Concept Videos
01:25Hepatitis
80
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
80
01:28Viral Hepatitis I: Introduction
22
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
22
01:30Inhibitors of Viral Protein Synthesis
57
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
57
01:24Cystic Fibrosis: Management
655
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
655
01:10Retrovirus Life Cycles
43.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
01:29Subviral Agents
927
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
927